Search results
AHA 2025 Highlights: New Insights on Icosapent Ethyl
Video Series
Navdeep Tangri
Research Area(s) / Expertise:
Author
Expertise
Prevention & Chronic ConditionsChronic Kidney DiseaseCardiovascular Kidney MetabolicMetabolic dysfunction-associated fatty liver disease (MAFLD)Heart Failure ComorbiditiesObesityCardiomyopathiesCardiomyopathies and Cardiac AmyloidosisHeart FailureDiabetesHeart Failure Diagnosis and ImagingHypertensionHeart Failure Devices
Krzysztof Filipiak
Author
José Ramón González Juanatey
Author
Avi Sabbag
Author
Marco Alings
Job title: Cardiologist/Electrophysiologist
Author
Michael S Firstenberg
Job title: Director of Research and Special Projects
Author
Francesco Saia
Job title: Interventional cardiologist
Author
Added:
1 year ago
Source:
Radcliffe Cardiology
AUTHOR: David RamseyAmerican Diabetes Scientific Sessions, 23 June 2024 – The data from three studies investigating glucagon-like peptide-1 (GLP-1) receptor agonists and dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) receptor agonists in patients with obesity was recently presented at a late-breaking session at the American Diabetes Association’s 84th Scientific Sessions in Orlando…
View more
Cristiana Vitale
Author